Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Myo-inositol vs Metformin in PCOS
NCT04204044Phase 1Unknown
- Sponsor
- Rashid Latif Medical College
- Start
- Nov 2020
- Primary completion
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of myo-inositol and metformin in polycystic ovary syndrome (PCOS) (3 arms), sponsored by Rashid Latif Medical College. Primary endpoints: Menstrual cycle regulation at 6 months and Change in weight at 6 months. Status: unknown.
02
Drugs
myo-inositolmetformin
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT04204044.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04204044.